Nystatin Powder: A Decades-Old Antifungal That Still Works, Even on Severe Burns
The reason nystatin stays relevant is also the reason it frustrates researchers: it barely absorbs into anything. Your gut doesn't take it up. Your skin doesn't take it up. That makes systemic toxicity very low, but it also means the powder itself dissolves poorly in water, doesn't penetrate deeply, and needs frequent reapplication. Modern pharmaceutical science is trying to solve exactly that problem.
How Nystatin Powder Is Actually Used
Nystatin is a polyene antifungal, meaning it targets fungal cell membranes. It's used topically for Candida infections on the skin and mucous membranes, including oral thrush, vaginal candidiasis, and infected burns. You'll find it in several forms:
- Oral suspensions (swish and swallow or spit)
- Pastilles (slow-dissolving lozenges)
- Creams
- Topical powders
Systematic reviews confirm it works for oral candidiasis, with pastilles and combination regimens performing especially well. Suspensions have been shown to be comparable to fluconazole in some clinical settings, which is notable since fluconazole is often considered the go-to systemic option.
Why the Raw Powder Has Real Limitations
For all its effectiveness, nystatin powder as a raw material has well-documented shortcomings:
| Limitation | What It Means for You |
|---|---|
| Very poor water solubility | The drug doesn't dissolve easily, which limits how much active ingredient contacts the infection |
| Limited tissue penetration | It works on surfaces but struggles to reach deeper fungal growth |
| Frequent application needed | You may need to apply or take it multiple times a day to maintain effective levels |
| Instability in some environments | The drug can degrade depending on conditions, potentially reducing potency |
These aren't deal-breakers for many infections, but they explain why researchers keep trying to build a better delivery system around the same active ingredient.
The New Generation of Nystatin Formulations
Much of the current research treats nystatin powder as a starting material, then engineers it into formats that stick around longer, dissolve better, and hit harder. The strategies fall into a few categories:
| Goal | Approach | Result |
|---|---|---|
| Better skin and mucosal residence | Chitosan microparticles, films, hydrogels loaded with nystatin | Sustained drug release with strong activity against Candida species, including C. auris |
| Improved oral delivery | Maltodextrin solid dispersions, self-emulsifying systems, spanlastic lozenges | Increased solubility, biofilm destruction, longer oral contact time, and better outcomes in animal studies |
| Enhanced stability and potency | Liposomes, novasomes, nanocapsules, transfersomes | Higher drug entrapment, lower minimum concentrations needed to inhibit fungi, and better cure rates compared to free powder |
The throughline here is clear: nystatin itself works. The challenge is keeping it where you need it, in a form it can actually act from.
The activity against C. auris is worth flagging. That's one of the more concerning drug-resistant Candida species to emerge in recent years, and chitosan-based nystatin formulations showed strong activity against it in lab testing.
Safety: Boring in the Best Way
Nystatin's safety profile is one of its strongest selling points. Because the drug is minimally absorbed from both the GI tract and the skin, systemic toxicity stays low. You're not loading your liver or kidneys with this medication when you use it topically or swallow a suspension.
The most common complaints are mild and local:
- Taste issues with oral formulations (suspensions in particular)
- Mild GI upset when taken by mouth
The research provided doesn't detail serious adverse effects, which tracks with nystatin's long clinical history as a well-tolerated topical agent.
Where the Powder Still Shines, and Where It Doesn't
Nystatin powder holds its ground best in straightforward surface-level Candida infections. Oral thrush, skin folds, and even severely infected burn wounds respond to it. Pastilles appear to offer an edge in oral candidiasis, likely because they dissolve slowly and maintain contact with the infected tissue longer than a liquid suspension.
Where nystatin powder alone falls short is in situations demanding deep tissue penetration, sustained drug levels without constant reapplication, or use in environments that degrade the drug. The available research doesn't directly compare nystatin powder to newer azole antifungals across all of these contexts, so it's hard to draw a universal ranking. What's clear is that the powder works, and reformulating it into modern delivery systems can meaningfully extend what it's capable of.
Choosing the Right Form for the Problem
If you're using nystatin or discussing it with a prescriber, the form matters as much as the drug itself:
- For oral thrush: pastilles or combination regimens have the strongest support. Suspensions work but may be comparable to fluconazole in some cases, making them one option among several.
- For skin infections: topical powder or cream applied to the affected area. Powder can be especially practical in moist skin folds where creams might not stay put.
- For burn wound infections: high-concentration topical powder (6,000,000 units/g) has demonstrated efficacy even against severe, deep fungal invasion.
- For drug-resistant Candida (like C. auris): newer chitosan-based formulations are showing promise in preclinical work, though these aren't yet standard clinical options.
Nystatin powder isn't flashy. It doesn't absorb, it doesn't circulate, and it needs help staying in place. But for topical Candida infections, from routine thrush to life-threatening burn wounds, the evidence says it still earns its spot in the antifungal lineup. The next generation of formulations may finally solve its biggest weaknesses without sacrificing the safety that made it a staple in the first place.
